Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange (Q35607575)

9 August 2017

title

Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange (English)

1 reference

9 August 2017

1 reference

A K Singh

1

1 reference

9 August 2017

S S Narsipur

series ordinal

2

1 reference

9 August 2017

publication date

17 November 2011

1 reference

Journal of Transplantation

9 August 2017

published in

1 reference

9 August 2017

volume

2011

1 reference

9 August 2017

page(s)

480642

1 reference

Creative Commons Attribution 3.0 Unported

9 August 2017

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Interchangeability of ciclosporin formulations in stable adult renal transplant recipients: comparison of Equoral and Neoral capsules in an international, multicenter, randomized, open-label trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235899

Bioequivalence testing of immunosuppressants: concepts and misconceptions

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235899

Healthcare costs in renal transplant recipients using branded versus generic ciclosporin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235899

Patients' perceptions of generic medications

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235899

Is there a relationship between patient beliefs or communication about generic drugs and medication utilization?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235899

Does bioequivalence between modified cyclosporine formulations translate into equal outcomes?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235899

Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235899

Drug substitution in transplantation: a National Kidney Foundation White Paper

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235899

Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235899

Cyclosporin pharmacokinetics in paediatric transplant recipients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235899

Cyclosporine bioavailability in heart-lung transplant candidates with cystic fibrosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235899

Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.

27 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F480642

Maintenance immunosuppressive therapy and generic cyclosporine A use in adult renal transplantation: a single center analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F480642

Differentiation of innovator versus generic cyclosporine via a drug interaction on sirolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F480642

Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F480642

Neoral-to-Gengraf conversion in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F480642

Assessment of the bioequivalence of a generic cyclosporine A by a randomized controlled trial in stable renal recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F480642

Report of the American Society of Transplantation Conference on Immunosuppressive Drugs and the Use of Generic Immunosuppressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F480642

Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235899

Pharmacokinetics of a new oral formulation of cyclosporine in liver transplant recipients.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235899

Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group

25 September 2018

1 reference

12 December 2020

The adverse impact of high cyclosporine. Clearance rates on the incidences of acute rejection and graft loss

1 reference

12 December 2020

Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

12 December 2020

From the Food and Drug Administration

1 reference

12 December 2020

Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year

1 reference

12 December 2020

Altered pharmacokinetics of cyclosporin in heart-lung transplant recipients with cystic fibrosis

1 reference

12 December 2020

Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulations

1 reference

12 December 2020

Cyclosporine pharmacokinetics and variability from a microemulsion formulation--a multicenter investigation in kidney transplant patients

1 reference

12 December 2020

The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function

1 reference

12 December 2020

Simple bioequivalence criteria: are they relevant to critical dose drugs? Experience gained from cyclosporine

1 reference

12 December 2020

Identifiers

DOI

10.1155/2011/480642

1 reference

9 August 2017

1 reference

9 August 2017

1 reference